Skip to content

Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders

A Efficacy and Cost-effectiveness Study of a Brief Interventions for Mood and Anxiety Disorders: Brief Intake, Treatment and Routine Outcome Monitoring (ROM)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01643642
Acronym
K&K
Enrollment
182
Registered
2012-07-18
Start date
2010-03-31
Completion date
2012-12-31
Last updated
2013-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorder, Depressive Disorder

Brief summary

This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.

Interventions

OTHERCognitive behavioral treatment/farmacotherapy intervention

Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM

OTHERTreatment As Usual

Other: Treatment As Usual

Sponsors

GGZ Rivierduinen
CollaboratorOTHER
Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male of female adolescents * Adolescents aged between 18 to 65 year * Adolescents main complaint: Mild to moderate anxiety and/or mood disorders with or without psychiatric and/or somatic co-morbidity * Adolescents with proper understanding of the Dutch language.

Exclusion criteria

* Adolescents with current psychotic or bipolar traits, * Adolescents with homicidal or suicidal risk * Adolescents with severe social disfunctioning * No proper understanding of the Dutch language

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of the interventionapproximately 3 years (start: march 2010).Effectiveness of the intervention is investigated by the main questionnaires: Web Screening Questionnaire (WSQ) and Brief Symptom Inventory (BSI) as conducted by ROM

Secondary

MeasureTime frameDescription
Cost-effectiveness interventionapproximately 3 years (start: march 2010).Cost-effectiveness is explored by an open questionnaire Trimbos/iMTA Questionnaire for Cost Associated with Psychiatric Illness (TIC-P). Additionally patient and therapist satisfaction about the intervention is explored.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026